EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma.

by Andreas-Claudius Hoffmann, Eray Goekkurt, Peter V Danenberg, Sylvia Lehmann, Gerhard Ehninger, Daniela E Aust, Jan Stoehlmacher-Williams
Published 2013-01-01

Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INT...

by Joseph Tintelnot, Eray Goekkurt, Mascha Binder, Peter Thuss-Patience, Sylvie Lorenzen, Jorge Riera Knorrenschild, Albrecht Kretzschmar, Thomas Ettrich, Udo Lindig, Lutz Jacobasch, Daniel Pink, Salah-Eddin Al-Batran, Axel Hinke, Susanna Hegewisch-Becker, Sven Nilsson, Carsten Bokemeyer, Alexander Stein
Published 2020-06-01

Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach—A Real World Data Analysis

by Louisa Hempel, Julia Veloso de Oliveira, Andreas Gaumann, Valeria Milani, Katrin Schweneker, Kristina Schenck, Bastian Fleischmann, Patrick Philipp, Stefanie Mederle, Arun Garg, Armin Piehler, Beate Gandorfer, Cordula Schick, Axel Kleespies, Ludger Sellmann, Marius Bartels, Thorsten Oliver Goetze, Alexander Stein, Eray Goekkurt, Lucia Pfitzner, Sebastian Robert, Dirk Hempel
Published 2021-09-01